A comparison of the inactive urinary kallikrein: Creatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 10, 1996, Pages 981-987

  Kyle, Phillips M ^a   Campbell, Sarah ^b   Buckley, Davina ^c   Kissane, Jennifer ^a   de Swiet, Michael ^a   Albano, Janet ^b   Millar, J Gavin ^b   Redman, Christopher W G ^c  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN; APROTININ; CREATININE; KALLIKREIN; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCREENING TEST; URINALYSIS;

ANGIOTENSIN II; CREATININE; FEMALE; HUMANS; KALLIKREINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0029824250     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09547.x     Document Type: Article

References (30)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogems and kininases. Am Soc Pharmacol Exp Ther 1992; 44: 1-80.
2. Saitoh S, Scicli G, Peterson E, Carretero OA. Effect of inhibiting renal kallikrein on prostaglandin E2, water and sodium excretion. Hypertension 1995; 25: 1008-1013.
3. Song Q, Chao J, Chao L. High level expression of human tissue kallikrein in the circulation induces hypotension in treansgenic mice. Immuno Pharmacol 1996; 32: 105-107.
4. Margolius HS, Chao J, Kaizu T. The effect of aldosterone and spironolactone on renal kallikrein in the rat. Clin Sci 1976; 51: 279-282.
5. Margolius HS, Pisano JJ, Geller R, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971; 2: 1063-1065.
6. Pisano JJ, Corthom J, Yates K, Pierce JV. The kallikrein-kinin system in the kidney. Contrib Nephrol 1978; 12: 116.
7. Mersey JH, Williams GH, Emanuel R, Dluhy RG, Wong PY, Moore TJ. Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension. J Clin Endocrinol Metab 1979; 48: 642-647.
8. Elebute OA, Mills IH. Urinary kallikrein in normal and hypertensive pregnancies. In: Lindheimer MD, Katz AI, Zuspan FP, editors. Hypertension in Pregnancy. New York : John Wiley and Sons, 1976: 329-338.
9. Karlberg BE, Wichman K. Hypertension in pregnancy. Prostaglandins, kinins and kallikrein. Scand J Clin Lab Invest 1984; Suppl 44:169-177.
10. Kovatz S, Arber I, Korzets Z, Rathaus M, Aderet NB, Bernheim I. Urinary kallikrein in normal pregnancy, pregnancy with hypertension, and toxaemia. Nephron 1985; 40:48-51.
11. Campbell SK, Farrer A, Albano JDM, Steel PJ, Millar JGB. The renal kallikrein system in pregnancy. In: Sharp F, Symonds EM, editors. Hypertension in Pregnancy. New York : Perinatology Press, 1987: 201-219.
12. Millar JGB, Campbell SK, Albano JDM, Higgins BR, Clark AD. Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample. Br J Obstet Gynaecol 1996; 103: 421-426.
13. Weir RJ, Brown JJ, Fraser R et al. Relationship between plasma renin, renin-substrate, angiotensin 11, aldosterone and electrolytes in normal pregnancy. J Clin Endocrinol Metab 1975; 40: 108-115.
14. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682-2689.
15. Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS. Bartter's syndrome: Urinary prostaglandin E-like material and kallilaeh, indomethacin effects. Ann Int Med 1977; 87: 281-286.
16. Vinci JM, Gill JR, Bowden RE, Pisano JJ, Izzzo JL, Radfar N. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase production. J Clin Invest 1978; 61: 1671-1682.
17. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1-3.
18. Oney T, Kaulhausen H. The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy. Am J Obstet Gynecol 1982; 142: 17-20.
19. CLASP collaborators. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619-629.
20. Amundsen E, Putter J, Friberger P, Knos M, Larsbraten M, Claeson G. Methods for the determination of glandular kalliin by means of a chromogenic tripeptide substrate. Medicine and Biology 1979; 120: 83-95.
21. Albano JDM, Campbell SK, Farrer A, Millar JGB. Gender differences in urinary kallikrein excretion in man. Clin Sci 1994; 86: 227-231.
22. Redman CWG, Jefferies M. Revised definition of pre-eclampsia. Lancet 1988; 1: 809-812.
23. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
24. Kyle PM, Buckley D, Kissane J, de Swiet M, Redman CWG. The Angiotensin Senstivity Test and low-dose aspirin are ineffective methods to predict and prevent preeclampsia. Am J Obstet Gynecol 1995; 173: 865-872.
25. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285-1293.
26. Zinner HS, Margolius HS, Rosener B, Kass EH. Familial aggregation of urinary kallikrein concentration in childhood. Am J Epidemiol 1976; 104: 126-132.
27. Zinner SH, Margolius HS, Rosner B, Kass EH. Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation 1978; 58: 908-915.
28. Roberts JM, Taylor RN, Musci J, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial disorder. Am J Obstet Gvnecol 1989; 161: 1200-1204.
29. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J obstet Gynecol 1993; 168: 1323-1330.
30. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170: 1458-1466.